BioDelivery Sciences Names Thomas Smith Chief Medical Officer

BioDelivery Sciences International (NASDAQ: [[ticker:BDSI]]) has appointed Thomas B. Smith to serve as chief medical officer. Smith comes to the Raleigh, NC, drug company from Charleston Laboratories in Jupiter, FL, where he was chief medical officer. His experience also includes executive positions at Ameritox, Mallinckrodt Pharmaceuticals (NYSE: [[ticker:MNK]]), and Covidien. BDSI develops products based on a proprietary drug delivery technology that administers medicine via a dissolvable film placed on the inside of the cheek.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.